Advances in Breast Oncology: The 2002 ASCO Meeting

Autor:	G. Singh-Ranger, Kefah Mokbel
Rok vydání:	2002
Předmět:	Oncology medicine.medical_specialty business.industry Sentinel lymph node General Medicine Evidence-based medicine medicine.disease Axilla Breast cancer medicine.anatomical_structure Docetaxel Internal medicine Adjuvant therapy Medicine Hormonal therapy business Tamoxifen medicine.drug
Zdroj:	Current Medical Research and Opinion. 18:401-406
ISSN:	1473-4877 0300-7995
DOI:	10.1185/030079902125001155
Popis:	At this year's American Society of Clinical Oncology (ASCO) meeting, a number of important advances in breast cancer diagnosis, treatment and prevention were reported. In this article, we review these current developments, focusing particularly on the ASCO technology assessment report--which discussed the adjuvant use of aromatase inhibitors in breast cancer--and other significant studies which were presented or updated: the role of taxanes in neoadjuvant and adjuvant therapy; current concepts regarding the timing of hormonal therapy during adjuvant chemotherapy; and cyclooxygenase-2 (COX-2) as a target for disruption in breast cancer treatment and prevention. With regards to advances in surgery, we review studies which were presented concerning the evolving role of sentinel lymph node biopsy in the management of the axilla in breast cancer, and review the latest meta-analysis on this subject presented at the meeting.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::391913cdf85c3599dbf8965227d6192e https://doi.org/10.1185/030079902125001155 Zobrazit plný text záznamu